BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27839968)

  • 1. Post-donation telephonic interview of blood donors providing an insight into delayed adverse reactions: First attempt in India.
    Tiwari AK; Aggarwal G; Dara RC; Arora D; Srivastava K; Raina V
    Transfus Apher Sci; 2017 Apr; 56(2):141-146. PubMed ID: 27839968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed adverse reactions in whole blood donors: Importance of active surveillance in identifying the missing gaps in the donor safety.
    Gupta AM; Bajpai M
    Indian J Med Res; 2023 Jan; 157(1):30-36. PubMed ID: 37040224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!
    Kaur S; Mittal K; Kaur R; Kaur G; Kaur P; Sood T
    Transfus Clin Biol; 2022 May; 29(2):141-146. PubMed ID: 34856397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed adverse reaction in donors after whole blood donation: Is it a matter of concern?
    Kumar R; Kaur P; Verma K; Rajeev K; Bhaskar B; Kumar S
    Transfus Clin Biol; 2023 May; 30(2):232-237. PubMed ID: 36638906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed adverse events in male plateletpheresis donors: Initial insights on donor safety.
    Gupta AM; Bajpai M
    J Clin Apher; 2020 Jan; 35(1):18-24. PubMed ID: 31663633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017).
    Bisht A; Marwaha N; Arora S; Patidar GK; Chhabra R
    Asian J Transfus Sci; 2021; 15(1):1-11. PubMed ID: 34349450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of delayed and immediate adverse events on the intention of future donations in whole blood and plateletpheresis donors.
    Gupta AM; Bajpai M
    J Clin Apher; 2021 Aug; 36(4):621-627. PubMed ID: 33942928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delayed adverse reactions to blood donation: From haemovigilance data to specific studies].
    Py JY; Durieux S; Barnoux M; Sapey T
    Transfus Clin Biol; 2016 Nov; 23(4):233-239. PubMed ID: 27769684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk predictors analysis of adverse donor reactions in whole blood donation.
    Prakash S; Das PK; Mishra D; Ray GK; Routray S; Naik A; Mukherjee S
    Transfus Clin Biol; 2020 Nov; 27(4):207-212. PubMed ID: 33027707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects in blood donors after whole-blood donation: a study of 1000 blood donors interviewed 3 weeks after whole-blood donation.
    Newman BH; Pichette S; Pichette D; Dzaka E
    Transfusion; 2003 May; 43(5):598-603. PubMed ID: 12702180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
    Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
    Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the probability of a blood donation adverse event based on 1000 interviewed whole-blood donors.
    Newman BH; Roth AJ
    Transfusion; 2005 Nov; 45(11):1715-21. PubMed ID: 16271095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds.
    Eder AF; Hillyer CD; Dy BA; Notari EP; Benjamin RJ
    JAMA; 2008 May; 299(19):2279-86. PubMed ID: 18492969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-ignored onsite adverse donor reaction among whole blood donors: A single center experience from India.
    Rajendran V; Paonam B; Chenna D; Mohan G; Shastry S; Jose P; Kandasamy D
    Transfus Clin Biol; 2022 May; 29(2):124-128. PubMed ID: 35031508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis.
    de Farias CLG; Bassolli L; Mendrone-Junior A; de Araújo Arrais C; Duran A; Rocha V; de Almeida-Neto C
    Transfus Apher Sci; 2022 Aug; 61(4):103424. PubMed ID: 35346602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
    Patidar GK; Sharma RR; Marwaha N
    Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative safety of automated two-unit red blood cell procedures and manual whole-blood collection in young donors.
    Benjamin RJ; Dy BA; Kennedy JM; Notari EP; Eder AF
    Transfusion; 2009 Sep; 49(9):1874-83. PubMed ID: 19538429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor vigilance data of a blood transfusion service: A multicenter analysis.
    Burkhardt T; Dimanski B; Karl R; Sievert U; Karl A; Hübler C; Tonn T; Sopvinik I; Ertl H; Moog R
    Transfus Apher Sci; 2015 Oct; 53(2):180-4. PubMed ID: 26074050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and risk factors for donor reactions in an anonymous blood donor survey.
    Goldman M; Osmond L; Yi QL; Cameron-Choi K; O'Brien SF
    Transfusion; 2013 Sep; 53(9):1979-84. PubMed ID: 23228195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-time whole blood donation: A critical step for donor safety and retention on first three donations.
    Gillet P; Rapaille A; Benoît A; Ceinos M; Bertrand O; de Bouyalsky I; Govaerts B; Lambermont M
    Transfus Clin Biol; 2015; 22(5-6):312-7. PubMed ID: 26476508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.